New Drug Blocks Out AIDS Virus

Susan Farley
Published Online: Saturday, October 1, 2005

At the recent International Congress on AIDS, Japanese researchers introduced a new HIV drug that blocks out the AIDS virus before it enters human cells. Known as AK602, the drug acts by attaching itself to the protein that serves as the virus' entryway into human cells. Whereas other AIDS medications lose their effectiveness when the virus develops a resistance to them, AK602 acts by addressing the human cells rather than the virus. Clinical trials were conducted on 40 US patients with AIDS who took 0.02 oz of AK602 bid for 10 days. The resulting percentage of HIV viruses dropped to an average of 1%. The researchers noted no reported side effects.

Ms. Farley is a freelance medical writer based in Wakefield, RI.

Latest Articles
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Latest Issues